This paper describes the experience of one surgical group 2a), chemotherapy, vaccine therapy and radiotherapy in managing patients with melanoma of the head and are being evaluated to determine the optimal approach. neck. Fifty-six patients were treated between 1977 and The correct management of patients with a high-risk 1993 and followed for between 2 and 18 years (mean (thick, deep) primary melanoma and clinically negative 7.5 years). The patients are divided into three groups. regional nodes is less clear. Until recently there were Twenty-four patients received, ªplanned definitive sur- two options, elective node dissection and a ªwatch and gery.º This is defined as local excision with adequate waitº policy, with therapeutic node dissection if and when margins and ª selective modified lymph node dissectionº the nodes became clinically positive. Clinical experience within two months of initial diagnosis for ªhigh riskº pa- and extensive studies of patients treated by elective node tients (superficial spreading or nodular melanoma thicker dissection suggest that a subroup of patients may benefit than 1 mm). Ten received ªnon-planned definitive sur- from elective nodal dissection, but give no guidance as to geryº, more than 2 months having elapsed since initial di- how such patients may be
European Journal of Plastic Surgery – Springer Journals
Published: Apr 15, 1999
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera